Te Ahumairangi Investment Management Ltd increased its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 43,297 shares of the company's stock after buying an additional 1,975 shares during the period. Procter & Gamble comprises approximately 1.6% of Te Ahumairangi Investment Management Ltd's holdings, making the stock its 17th largest position. Te Ahumairangi Investment Management Ltd's holdings in Procter & Gamble were worth $7,379,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Cladis Investment Advisory LLC boosted its holdings in Procter & Gamble by 5.2% in the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock worth $806,000 after buying an additional 236 shares during the period. FAS Wealth Partners Inc. boosted its holdings in Procter & Gamble by 2.0% in the 4th quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock worth $4,642,000 after buying an additional 549 shares during the period. Benjamin Edwards Inc. boosted its holdings in Procter & Gamble by 120.7% in the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after buying an additional 199,258 shares during the period. Capital Investment Advisory Services LLC boosted its holdings in Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after buying an additional 4,562 shares during the period. Finally, World Investment Advisors boosted its holdings in Procter & Gamble by 6.0% in the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after buying an additional 2,886 shares during the period. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Price Performance
Shares of NYSE PG traded down $0.56 during mid-day trading on Wednesday, hitting $157.43. 1,864,474 shares of the company's stock traded hands, compared to its average volume of 8,011,015. The company's 50-day moving average is $156.42 and its two-hundred day moving average is $162.37. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market capitalization of $368.76 billion, a P/E ratio of 24.19, a PEG ratio of 4.14 and a beta of 0.36. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the prior year, the company earned $1.40 EPS. The business's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio is 64.98%.
Wall Street Analysts Forecast Growth
Several brokerages have commented on PG. Barclays set a $164.00 price target on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. BNP Paribas reiterated an "outperform" rating and issued a $177.00 price target on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reiterated an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $175.12.
Read Our Latest Stock Analysis on PG
Insider Buying and Selling
In related news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares of the company's stock, valued at $5,532,120.48. This represents a 22.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Ma. Fatima Francisco sold 9,100 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,431,157.00. Following the completion of the sale, the chief executive officer directly owned 27,295 shares in the company, valued at $4,292,684.65. This trade represents a 25.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 120,181 shares of company stock worth $18,918,012 over the last three months. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report